Retrovirus-based vectors for transient and permanent cell modification

Current Opinion in Pharmacology

Volumn 24, Issue , 2015, Pages 135-146

  Schott, Juliane W ^a   Hoffmann, Dirk ^a   Schambach, Axel ^a,b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NANOPARTICLE; RETROVIRUS VECTOR; MESSENGER RNA; PROTEIN;

ARTICLE; BIOTECHNOLOGY; CELL MODIFICATION; DNA TEMPLATE; EPISOME; GENE EXPRESSION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROCEDURES CONCERNING CELLS; PROTEIN TRANSPORT; RETROVIRAL EPISOME TRANSFER; RETROVIRAL MRNA TRANSFER; RETROVIRAL PROTEIN TRANSFER; RNA STRUCTURE; RNA TEMPLATE; RNA TRANSPORT; SAFETY; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; ANIMAL; GENE VECTOR; GENETICS; PLASMID; RETROVIRIDAE;

ANIMALS; GENETIC VECTORS; HUMANS; PLASMIDS; PROTEINS; RETROVIRIDAE; RNA, MESSENGER;

EID: 84943249267     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2015.09.004     Document Type: Review

References (90)

1. J.W. Schott, M. Galla, T. Godinho, C. Baum, and A. Schambach Viral and non-viral approaches for transient delivery of mRNA and proteins Curr Gene Ther 11 2011 382 398
2. M. Galla, E. Will, J. Kraunus, L. Chen, and C. Baum Retroviral pseudotransduction for targeted cell manipulation Mol Cell 16 2004 309 315
3. J.W. Schott, D. Hoffmann, T. Maetzig, F.J. Müller, D. Steinemann, D. Zychlinski, T. Cantz, C. Baum, and A. Schambach Improved retroviral episome transfer of transcription factors enables sustained cell fate modification Gene Ther 21 2014 938 949
4. C. Baum, A. Schambach, J. Bohne, and M. Galla Retrovirus vectors: toward the plentivirus? Mol Ther 13 2006 1050 1063
5. T. Maetzig, M. Galla, C. Baum, and A. Schambach Gammaretroviral vectors: biology, technology and application Viruses 3 2011 677 713
6. K. Wanisch, and R.J. Yáñez-Muñoz Integration-deficient lentiviral vectors: a slow coming of age Mol Ther 17 2009 1316 1332
7. T. Maetzig, C. Baum, and A. Schambach Retroviral protein transfer: falling apart to make an impact Curr Gene Ther 12 2012 389 409
8. T. Dull, R. Zufferey, M. Kelly, R.J. Mandel, M. Nguyen, D. Trono, and L. Naldini A third-generation lentivirus vector with a conditional packaging system J Virol 72 1998 8463 8471
9. J. Ellis Silencing and variegation of gammaretrovirus and lentivirus vectors Hum Gene Ther 16 2005 1241 1246
10. R. Ghirlando, K. Giles, H. Gowher, T. Xiao, Z. Xu, H. Yao, and G. Felsenfeld Chromatin domains, insulators, and the regulation of gene expression Biochim Biophys Acta 1819 2012 644 651
11. S. Rival-Gervier, M.Y. Lo, S. Khattak, P. Pasceri, M.C. Lorincz, and J. Ellis Kinetics and epigenetics of retroviral silencing in mouse embryonic stem cells defined by deletion of the D4Z4 element Mol Ther 21 2013 1536 1550
12. F. Grosveld, G.B. van Assendelft, D.R. Greaves, and G. Kollias Position-independent, high-level expression of the human beta-globin gene in transgenic mice Cell 51 1987 975 985
13. H. Hanawa, P.W. Hargrove, S. Kepes, D.K. Srivastava, A.W. Nienhuis, and D.A. Persons Extended beta-globin locus control region elements promote consistent therapeutic expression of a gamma-globin lentiviral vector in murine beta-thalassemia Blood 104 2004 2281 2290
14. M.N. Antoniou, K.A. Skipper, and O. Anakok Optimizing retroviral gene expression for effective therapies Hum Gene Ther 24 2013 363 374
15. F. Zhang, A.R. Frost, M.P. Blundell, O. Bales, M.N. Antoniou, and A.J. Thrasher A ubiquitous chromatin opening element (UCOE) confers resistance to DNA methylation-mediated silencing of lentiviral vectors Mol Ther 18 2010 1640 1649
16. C. Brendel, U. Muller-Kuller, S. Schultze-Strasser, S. Stein, L. Chen-Wichmann, A. Krattenmacher, H. Kunkel, A. Dillmann, M.N. Antoniou, and M. Grez Physiological regulation of transgene expression by a lentiviral vector containing the A2UCOE linked to a myeloid promoter Gene Ther 19 2012 1018 1029
17. N. Pfaff, N. Lachmann, M. Ackermann, S. Kohlscheen, C. Brendel, T. Maetzig, H. Niemann, M.N. Antoniou, M. Grez, A. Schambach, and et al. A ubiquitous chromatin opening element prevents transgene silencing in pluripotent stem cells and their differentiated progeny Stem Cells 31 2013 488 499
18. M. Ackermann, N. Lachmann, S. Hartung, R. Eggenschwiler, N. Pfaff, C. Happle, A. Mucci, G. Gohring, H. Niemann, G. Hansen, and et al. Promoter and lineage independent anti-silencing activity of the A2 ubiquitous chromatin opening element for optimized human pluripotent stem cell-based gene therapy Biomaterials 35 2014 1531 1542
19. U. Müller-Kuller, M. Ackermann, S. Kolodziej, C. Brendel, J. Fritsch, N. Lachmann, H. Kunkel, J. Lausen, A. Schambach, T. Moritz, and et al. A minimal ubiquitous chromatin opening element (UCOE) effectively prevents silencing of juxtaposed heterologous promoters by epigenetic remodeling in multipotent and pluripotent stem cells Nucleic Acids Res 43 2015 1577 1592
20. R.A. Katz, E. Jack-Scott, A. Narezkina, I. Palagin, P. Boimel, J. Kulkosky, E. Nicolas, J.G. Greger, and A.M. Skalka High-frequency epigenetic repression and silencing of retroviruses can be antagonized by histone deacetylase inhibitors and transcriptional activators, but uniform reactivation in cell clones is restricted by additional mechanisms J Virol 81 2007 2592 2604
21. D. Fenard, D. Ingrao, A. Seye, J. Buisset, S. Genries, S. Martin, A. Kichler, and A. Galy Vectofusin-1, a new viral entry enhancer, strongly promotes lentiviral transduction of human hematopoietic stem cells Mol Ther Nucleic Acids 2 2013 e90
22. J.M. Johnston, G. Denning, R. Moot, D. Whitehead, J. Shields, J.M. Le Doux, C.B. Doering, and H.T. Spencer High-throughput screening identifies compounds that enhance lentiviral transduction Gene Ther 21 2014 1008 1020
23. S. Hacein-Bey-Abina, C. von Kalle, M. Schmidt, F. Le Deist, N. Wulffraat, E. McIntyre, I. Radford, J.L. Villeval, C.C. Fraser, M. Cavazzana-Calvo, and et al. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency N Engl J Med 348 2003 255 256
24. S. Hacein-Bey-Abina, C. Von Kalle, M. Schmidt, M.P. McCormack, N. Wulffraat, P. Leboulch, A. Lim, C.S. Osborne, R. Pawliuk, E. Morillon, and et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1 Science 302 2003 415 419
25. S. Hacein-Bey-Abina, A. Garrigue, G.P. Wang, J. Soulier, A. Lim, E. Morillon, E. Clappier, L. Caccavelli, E. Delabesse, K. Beldjord, and et al. Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1 J Clin Invest 118 2008 3132 3142
26. S.J. Howe, M.R. Mansour, K. Schwarzwaelder, C. Bartholomae, M. Hubank, H. Kempski, M.H. Brugman, K. Pike-Overzet, S.J. Chatters, D. de Ridder, and et al. Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients J Clin Invest 118 2008 3143 3150
27. S. Stein, M.G. Ott, S. Schultze-Strasser, A. Jauch, B. Burwinkel, A. Kinner, M. Schmidt, A. Kramer, J. Schwable, H. Glimm, and et al. Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease Nat Med 16 2010 198 204
28. C.J. Braun, K. Boztug, A. Paruzynski, M. Witzel, A. Schwarzer, M. Rothe, U. Modlich, R. Beier, G. Gohring, D. Steinemann, and et al. Gene therapy for Wiskott-Aldrich syndrome - long-term efficacy and genotoxicity Sci Transl Med 6 2014 227ra33
29. A.R. Schröder, P. Shinn, H. Chen, C. Berry, J.R. Ecker, and F. Bushman HIV-1 integration in the human genome favors active genes and local hotspots Cell 110 2002 521 529
30. X. Wu, Y. Li, B. Crise, and S.M. Burgess Transcription start regions in the human genome are favored targets for MLV integration Science 300 2003 1749 1751
31. R.S. Mitchell, B.F. Beitzel, A.R. Schroder, P. Shinn, H. Chen, C.C. Berry, J.R. Ecker, and F.D. Bushman Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences PLoS Biol 2 2004 E234
32. U. Modlich, S. Navarro, D. Zychlinski, T. Maetzig, S. Knoess, M.H. Brugman, A. Schambach, S. Charrier, A. Galy, A.J. Thrasher, and et al. Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors Mol Ther 17 2009 1919 1928
33. M. Rothe, A. Schambach, and L. Biasco Safety of gene therapy: new insights to a puzzling case Curr Gene Ther 14 2014 429 436
34. N. Cartier, S. Hacein-Bey-Abina, C.C. Bartholomae, G. Veres, M. Schmidt, I. Kutschera, M. Vidaud, U. Abel, L. Dal-Cortivo, L. Caccavelli, and et al. Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy Science 326 2009 818 823
35. M. Cavazzana-Calvo, E. Payen, O. Negre, G. Wang, K. Hehir, F. Fusil, J. Down, M. Denaro, T. Brady, K. Westerman, and et al. Transfusion independence and HMGA2 activation after gene therapy of human beta-thalassaemia Nature 467 2010 318 322
36. A. Aiuti, L. Biasco, S. Scaramuzza, F. Ferrua, M.P. Cicalese, C. Baricordi, F. Dionisio, A. Calabria, S. Giannelli, M.C. Castiello, and et al. Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome Science 341 2013 1233151
37. A. Biffi, E. Montini, L. Lorioli, M. Cesani, F. Fumagalli, T. Plati, C. Baldoli, S. Martino, A. Calabria, S. Canale, and et al. Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy Science 341 2013 1233158
38. E. Montini, D. Cesana, M. Schmidt, F. Sanvito, C.C. Bartholomae, M. Ranzani, F. Benedicenti, L.S. Sergi, A. Ambrosi, M. Ponzoni, and et al. The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy J Clin Invest 119 2009 964 975
39. S.F. Yu, T. von Rüden, P.W. Kantoff, C. Garber, M. Seiberg, U. Rüther, W.F. Anderson, E.F. Wagner, and E. Gilboa Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells Proc Natl Acad Sci U S A 83 1986 3194 3198
40. R. Zufferey, T. Dull, R.J. Mandel, A. Bukovsky, D. Quiroz, L. Naldini, and D. Trono Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery J Virol 72 1998 9873 9880
41. S. Hacein-Bey-Abina, S.Y. Pai, H.B. Gaspar, M. Armant, C.C. Berry, S. Blanche, J. Bleesing, J. Blondeau, H. de Boer, K.F. Buckland, and et al. A modified gamma-retrovirus vector for X-linked severe combined immunodeficiency N Engl J Med 371 2014 1407 1417
42. J.D. Suerth, T. Maetzig, M.H. Brugman, N. Heinz, J.U. Appelt, K.B. Kaufmann, M. Schmidt, M. Grez, U. Modlich, C. Baum, and et al. Alpharetroviral self-inactivating vectors: long-term transgene expression in murine hematopoietic cells and low genotoxicity Mol Ther 20 2012 1022 1032
43. K.B. Kaufmann, C. Brendel, J.D. Suerth, U. Mueller-Kuller, L. Chen-Wichmann, J. Schwable, S. Pahujani, H. Kunkel, A. Schambach, C. Baum, and et al. Alpharetroviral vector-mediated gene therapy for X-CGD: functional correction and lack of aberrant splicing Mol Ther 21 2013 648 661
44. A. Moiani, J.D. Suerth, F. Gandolfi, E. Rizzi, M. Severgnini, G. De Bellis, A. Schambach, and F. Mavilio Genome-wide analysis of alpharetroviral integration in human hematopoietic stem/progenitor cells Genes (Basel) 5 2014 415 429
45. M.B. Banasik, and P.B. McCray Jr. Integrase-defective lentiviral vectors: progress and applications Gene Ther 17 2010 150 157
46. M. Bayer, B. Kantor, A. Cockrell, H. Ma, B. Zeithaml, X. Li, T. McCown, and T. Kafri A large U3 deletion causes increased in vivo expression from a nonintegrating lentiviral vector Mol Ther 16 2008 1968 1976
47. T.C. Pierson, T.L. Kieffer, C.T. Ruff, C. Buck, S.J. Gange, and R.F. Siliciano Intrinsic stability of episomal circles formed during human immunodeficiency virus type 1 replication J Virol 76 2002 4138 4144
48. L. Apolonia, S.N. Waddington, C. Fernandes, N.J. Ward, G. Bouma, M.P. Blundell, A.J. Thrasher, M.K. Collins, and N.J. Philpott Stable gene transfer to muscle using non-integrating lentiviral vectors Mol Ther 15 2007 1947 1954
49. R.J. Yáñez-Muñoz, K.S. Balaggan, A. MacNeil, S.J. Howe, M. Schmidt, A.J. Smith, P. Buch, R.E. MacLaren, P.N. Anderson, S.E. Barker, and et al. Effective gene therapy with nonintegrating lentiviral vectors Nat Med 12 2006 348 353
50. S. Philippe, C. Sarkis, M. Barkats, H. Mammeri, C. Ladroue, C. Petit, J. Mallet, and C. Serguera Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo Proc Natl Acad Sci U S A 103 2006 17684 17689
51. S.C. Verghese, N.A. Goloviznina, A.M. Skinner, H.J. Lipps, and P. Kurre S/MAR sequence confers long-term mitotic stability on non-integrating lentiviral vector episomes without selection Nucleic Acids Res 42 2014 e53
52. J. Vargas Jr., M.E. Klotman, and A. Cara Conditionally replicating lentiviral-hybrid episomal vectors for suicide gene therapy Antiviral Res 80 2008 288 294
53. R. Lu, N. Nakajima, W. Hofmann, M. Benkirane, K.T. Jeang, J. Sodroski, and A. Engelman Simian virus 40-based replication of catalytically inactive human immunodeficiency virus type 1 integrase mutants in nonpermissive T cells and monocyte-derived macrophages J Virol 78 2004 658 668
54. H. Kymäläinen, J.U. Appelt, F.A. Giordano, A.F. Davies, C.M. Ogilvie, S.G. Ahmed, S. Laufs, M. Schmidt, J. Bode, R.J. Yáñez-Muñoz, and et al. Long-term episomal transgene expression from mitotically stable integration-deficient lentiviral vectors Hum Gene Ther 25 2014 428 442
55. J.W. Schott, N.M. Jaeschke, D. Hoffmann, T. Maetzig, M. Ballmaier, T. Godinho, T. Cathomen, and A. Schambach Deciphering the impact of parameters influencing transgene expression kinetics after repeated cell transduction with integration-deficient retroviral vectors Cytometry A 2015
56. S. Bobis-Wozowicz, M. Galla, J. Alzubi, J. Kuehle, C. Baum, A. Schambach, and T. Cathomen Non-integrating gamma-retroviral vectors as a versatile tool for transient zinc-finger nuclease delivery Sci Rep 4 2014 4656
57. J. Vargas Jr., G.L. Gusella, V. Najfeld, M.E. Klotman, and A. Cara Novel integrase-defective lentiviral episomal vectors for gene transfer Hum Gene Ther 15 2004 361 372
58. J.B. Weinberg, T.J. Matthews, B.R. Cullen, and M.H. Malim Productive human immunodeficiency virus type 1 (HIV-1) infection of nonproliferating human monocytes J Exp Med 174 1991 1477 1482
59. M.I. Bukrinsky, N. Sharova, M.P. Dempsey, T.L. Stanwick, A.G. Bukrinskaya, S. Haggerty, and M. Stevenson Active nuclear import of human immunodeficiency virus type 1 preintegration complexes Proc Natl Acad Sci U S A 89 1992 6580 6584
60. T. Roe, T.C. Reynolds, G. Yu, and P.O. Brown Integration of murine leukemia virus DNA depends on mitosis Embo J 12 1993 2099 2108
61. W.M. Schneider, D.T. Wu, V. Amin, S. Aiyer, and M.J. Roth MuLV IN mutants responsive to HDAC inhibitors enhance transcription from unintegrated retroviral DNA Virology 426 2012 188 196
62. L.P. Pelascini, J.M. Janssen, and M.A. Gonçalves Histone deacetylase inhibition activates transgene expression from integration-defective lentiviral vectors in dividing and non-dividing cells Hum Gene Ther 24 2013 78 96
63. L.P. Pelascini, I. Maggio, J. Liu, M. Holkers, T. Cathomen, and M.A. Goncalves Histone deacetylase inhibition rescues gene knockout levels achieved with integrase-defective lentiviral vectors encoding zinc-finger nucleases Hum Gene Ther Methods 24 2013 399 411
64. T. Suwanmanee, G. Hu, T. Gui, C.C. Bartholomae, I. Kutschera, C. von Kalle, M. Schmidt, P.E. Monahan, and T. Kafri Integration-deficient lentiviral vectors expressing codon-optimized R338L human FIX restore normal hemostasis in Hemophilia B mice Mol Ther 22 2014 567 574
65. S.S. Yu, K. Dan, H. Chono, E. Chatani, J. Mineno, and I. Kato Transient gene expression mediated by integrase-defective retroviral vectors Biochem Biophys Res Commun 368 2008 942 947
66. S.J. Nightingale, R.P. Hollis, K.A. Pepper, D. Petersen, X.J. Yu, C. Yang, I. Bahner, and D.B. Kohn Transient gene expression by nonintegrating lentiviral vectors Mol Ther 13 2006 1121 1132
67. Y. Lin, and A.S. Waldman Capture of DNA sequences at double-strand breaks in mammalian chromosomes Genetics 158 2001 1665 1674
68. H. Ebina, Y. Kanemura, Y. Suzuki, K. Urata, N. Misawa, and Y. Koyanagi Integrase-independent HIV-1 infection is augmented under conditions of DNA damage and produces a viral reservoir Virology 427 2012 44 50
69. B. Kantor, M. Bayer, H. Ma, J. Samulski, C. Li, T. McCown, and T. Kafri Notable reduction in illegitimate integration mediated by a PPT-deleted, nonintegrating lentiviral vector Mol Ther 19 2010 547 556
70. S.U. Tareen, B. Kelley-Clarke, C.J. Nicolai, L.A. Cassiano, L.T. Nelson, M.M. Slough, C.D. Vin, J.M. Odegard, D.D. Sloan, N. Van Hoeven, and et al. Design of a novel integration-deficient lentivector technology that incorporates genetic and posttranslational elements to target human dendritic cells Mol Ther 22 2014 575 587
71. H. Saida, Y. Matsuzaki, K. Takayama, A. Iizuka, A. Konno, S. Yanagi, and H. Hirai One-year follow-up of transgene expression by integrase-defective lentiviral vectors and their therapeutic potential in spinocerebellar ataxia model mice Gene Ther 21 2014 820 827
72. M. Galla, A. Schambach, C.S. Falk, T. Maetzig, J. Kuehle, K. Lange, D. Zychlinski, N. Heinz, M.H. Brugman, G. Göhring, and et al. Avoiding cytotoxicity of transposases by dose-controlled mRNA delivery Nucleic Acids Res 39 2011 7147 7160
73. T. Hope Improving the post-transcriptional aspects of lentiviral vectors Curr Top Microbiol Immunol 261 2002 179 189
74. M.V. Hamann, N. Stanke, E. Müllers, K. Stirnnagel, S. Hütter, B. Artegiani, S. Bragado Alonso, F. Calegari, and D. Lindemann Efficient transient genetic manipulation in vitro and in vivo by prototype foamy virus-mediated nonviral RNA transfer Mol Ther 22 2014 1460 1471
75. C. Voelkel, M. Galla, T. Maetzig, E. Warlich, J. Kuehle, D. Zychlinski, J. Bode, T. Cantz, A. Schambach, and C. Baum Protein transduction from retroviral Gag precursors Proc Natl Acad Sci U S A 107 2010 7805 7810
76. D. Schenkwein, V. Turkki, H.R. Kärkkäinen, K. Airenne, and S. Ylä-Herttuala Production of HIV-1 integrase fusion protein-carrying lentiviral vectors for gene therapy and protein transduction Hum Gene Ther 21 2010 589 602
77. T. Aoki, K. Miyauchi, E. Urano, R. Ichikawa, and J. Komano Protein transduction by pseudotyped lentivirus-like nanoparticles Gene Ther 18 2011 936 941
78. X. Wu, H. Liu, H. Xiao, J. Kim, P. Seshaiah, G. Natsoulis, J.D. Boeke, B.H. Hahn, and J.C. Kappes Targeting foreign proteins to human immunodeficiency virus particles via fusion with Vpr and Vpx J Virol 69 1995 3389 3398
79. S. Peretti, I. Schiavoni, K. Pugliese, and M. Federico Cell death induced by the herpes simplex virus-1 thymidine kinase delivered by human immunodeficiency virus-1-based virus-like particles Mol Ther 12 2005 1185 1196
80. N. Link, C. Aubel, J.M. Kelm, R.R. Marty, D. Greber, V. Djonov, J. Bourhis, W. Weber, and M. Fussenegger Therapeutic protein transduction of mammalian cells and mice by nucleic acid-free lentiviral nanoparticles Nucleic Acids Res 34 2006 e16
81. J.A. Briggs, M.N. Simon, I. Gross, H.G. Krausslich, S.D. Fuller, V.M. Vogt, and M.C. Johnson The stoichiometry of Gag protein in HIV-1 Nat Struct Mol Biol 11 2004 672 675
82. T. Aoki, S. Shimizu, E. Urano, Y. Futahashi, M. Hamatake, H. Tamamura, K. Terashima, T. Murakami, N. Yamamoto, and J. Komano Improvement of lentiviral vector-mediated gene transduction by genetic engineering of the structural protein Pr55 Gag Gene Ther 17 2010 1124 1133
83. D.T. Wu, and M.J. Roth MLV based viral-like-particles for delivery of toxic proteins and nuclear transcription factors Biomaterials 35 2014 8416 8426
84. S.J. Kaczmarczyk, K. Sitaraman, H.A. Young, S.H. Hughes, and D.K. Chatterjee Protein delivery using engineered virus-like particles Proc Natl Acad Sci U S A 108 2011 16998 17003
85. L.B. Couto, and K.A. High Viral vector-mediated RNA interference Curr Opin Pharmacol 10 2010 534 542
86. T.H. Hutson, E. Foster, J.M. Dawes, R. Hindges, R.J. Yanez-Munoz, and L.D. Moon Lentiviral vectors encoding short hairpin RNAs efficiently transduce and knockdown LINGO-1 but induce an interferon response and cytotoxicity in central nervous system neurones J Gene Med 14 2012 299 315
87. M. Galla, A. Schambach, G.J. Towers, and C. Baum Cellular restriction of retrovirus particle-mediated mRNA transfer J Virol 82 2008 3069 3077
88. Y. Cai, R.O. Bak, and J.G. Mikkelsen Targeted genome editing by lentiviral protein transduction of zinc-finger and TAL-effector nucleases Elife 3 2014 e01911
89. J. Kuehle, S. Turan, T. Cantz, D. Hoffmann, J.D. Suerth, T. Maetzig, D. Zychlinski, C. Klein, D. Steinemann, C. Baum, and et al. Modified lentiviral LTRs allow Flp recombinase-mediated cassette exchange and in vivo tracing of "factor-free induced pluripotent stem cells Mol Ther 22 2014 919 928
90. C. Huret, D. Desjardins, M. Miyalou, B. Levacher, M. Amadoudji Zin, O. Bonduelle, B. Combadiere, C. Dalba, D. Klatzmann, and B. Bellier Recombinant retrovirus-derived virus-like particle-based vaccines induce hepatitis C virus-specific cellular and neutralizing immune responses in mice Vaccine 31 2013 1540 1547